These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15870177)

  • 1. NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes.
    Feuerhake F; Kutok JL; Monti S; Chen W; LaCasce AS; Cattoretti G; Kurtin P; Pinkus GS; de Leval L; Harris NL; Savage KJ; Neuberg D; Habermann TM; Dalla-Favera R; Golub TR; Aster JC; Shipp MA
    Blood; 2005 Aug; 106(4):1392-9. PubMed ID: 15870177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.
    Savage KJ; Monti S; Kutok JL; Cattoretti G; Neuberg D; De Leval L; Kurtin P; Dal Cin P; Ladd C; Feuerhake F; Aguiar RC; Li S; Salles G; Berger F; Jing W; Pinkus GS; Habermann T; Dalla-Favera R; Harris NL; Aster JC; Golub TR; Shipp MA
    Blood; 2003 Dec; 102(12):3871-9. PubMed ID: 12933571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma.
    Rodig SJ; Savage KJ; LaCasce AS; Weng AP; Harris NL; Shipp MA; Hsi ED; Gascoyne RD; Kutok JL
    Am J Surg Pathol; 2007 Jan; 31(1):106-12. PubMed ID: 17197926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of IKBA coding region mutations in primary mediastinal large B-cell lymphoma and the host response subtype of diffuse large B-cell lymphoma.
    Takahashi H; Feuerhake F; Monti S; Kutok JL; Aster JC; Shipp MA
    Blood; 2006 Jan; 107(2):844-5. PubMed ID: 16401828
    [No Abstract]   [Full Text] [Related]  

  • 5. Alternative and canonical NF-kB pathways DNA-binding hierarchies networks define Hodgkin lymphoma and Non-Hodgkin diffuse large B Cell lymphoma respectively.
    Gamboa-Cedeño AM; Castillo M; Xiao W; Waldmann TA; Ranuncolo SM
    J Cancer Res Clin Oncol; 2019 Jun; 145(6):1437-1448. PubMed ID: 30941572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells.
    Davis RE; Brown KD; Siebenlist U; Staudt LM
    J Exp Med; 2001 Dec; 194(12):1861-74. PubMed ID: 11748286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a chemokine receptor profile characteristic for mediastinal large B-cell lymphoma.
    Rehm A; Anagnostopoulos I; Gerlach K; Broemer M; Scheidereit C; Jöhrens K; Hübler M; Hetzer R; Stein H; Lipp M; Dörken B; Höpken UE
    Int J Cancer; 2009 Nov; 125(10):2367-74. PubMed ID: 19536742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD23 expression in mediastinal large B-cell lymphomas.
    Calaminici M; Piper K; Lee AM; Norton AJ
    Histopathology; 2004 Dec; 45(6):619-24. PubMed ID: 15569053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile.
    Chin M; Herscovitch M; Zhang N; Waxman DJ; Gilmore TD
    Oncogene; 2009 May; 28(20):2100-11. PubMed ID: 19377508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma.
    Traverse-Glehen A; Pittaluga S; Gaulard P; Sorbara L; Alonso MA; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2005 Nov; 29(11):1411-21. PubMed ID: 16224207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas.
    Houldsworth J; Olshen AB; Cattoretti G; Donnelly GB; Teruya-Feldstein J; Qin J; Palanisamy N; Shen Y; Dyomina K; Petlakh M; Pan Q; Zelenetz AD; Dalla-Favera R; Chaganti RS
    Blood; 2004 Mar; 103(5):1862-8. PubMed ID: 14615382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
    Green MR; Monti S; Rodig SJ; Juszczynski P; Currie T; O'Donnell E; Chapuy B; Takeyama K; Neuberg D; Golub TR; Kutok JL; Shipp MA
    Blood; 2010 Oct; 116(17):3268-77. PubMed ID: 20628145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
    Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma.
    Li L; Xu-Monette ZY; Ok CY; Tzankov A; Manyam GC; Sun R; Visco C; Zhang M; Montes-Moreno S; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Wang J; Parsons BM; Winter JN; Piris MA; Pham LV; Medeiros LJ; Young KH
    Oncotarget; 2015 Sep; 6(27):23157-80. PubMed ID: 26324762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling.
    Lam LT; Davis RE; Pierce J; Hepperle M; Xu Y; Hottelet M; Nong Y; Wen D; Adams J; Dang L; Staudt LM
    Clin Cancer Res; 2005 Jan; 11(1):28-40. PubMed ID: 15671525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.
    Starczynowski DT; Trautmann H; Pott C; Harder L; Arnold N; Africa JA; Leeman JR; Siebert R; Gilmore TD
    Oncogene; 2007 Apr; 26(19):2685-94. PubMed ID: 17072339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone acetyltransferase p300 is a coactivator for transcription factor REL and is C-terminally truncated in the human diffuse large B-cell lymphoma cell line RC-K8.
    Garbati MR; Alço G; Gilmore TD
    Cancer Lett; 2010 May; 291(2):237-45. PubMed ID: 19948376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCL6 represses NFkappaB activity in diffuse large B-cell lymphomas.
    Perez-Rosado A; Artiga M; Vargiu P; Sanchez-Aguilera A; Alvarez-Barrientos A; Piris M
    J Pathol; 2008 Mar; 214(4):498-507. PubMed ID: 18189332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bortezomib inhibits proteasomal degradation of IκBα and induces mitochondrial dependent apoptosis in activated B-cell diffuse large B-cell lymphoma.
    Bu R; Hussain AR; Al-Obaisi KA; Ahmed M; Uddin S; Al-Kuraya KS
    Leuk Lymphoma; 2014 Feb; 55(2):415-24. PubMed ID: 23697845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of I kappa B alpha and I kappa B beta and sustained activation of nuclear factor-kappa B/c-Rel.
    Yi AK; Krieg AM
    J Immunol; 1998 Feb; 160(3):1240-5. PubMed ID: 9570540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.